| Spirig HealthCare AG - Rivaroxaban vascular Spirig HC 2.5 mg, Filmtabletten | | 68551 | | 01 | | Rivaroxaban vascular Spirig HC 2.5 mg | | Filmtabletten | | B01AF01 | | Rivaroxaban | | 16.03.2023 | | |
| | Composition | | rivaroxabanum 2.5 mg, cellulosum microcristallinum, lactosum monohydricum 58.03 mg, povidonum K 30, amylum pregelificatum, crospovidonum, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), pro compresso obducto corresp. natrium 0.053 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivaroxabanum | 2.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Amylum Pregelificatum | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 58.03 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| |
|
